- Home
- NVAX vs MLNK Comparison
NVAX vs MLNK Comparison
Compare NVAX & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- MLNK
- Stock Information
- Founded
- NVAX 1987
- MLNK 1998
- Country
- NVAX United States
- MLNK United States
- Employees
- NVAX N/A
- MLNK N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- MLNK Computer Software: Prepackaged Software
- Sector
- NVAX Health Care
- MLNK Technology
- Exchange
- NVAX Nasdaq
- MLNK Nasdaq
- Market Cap
- NVAX 1.3B
- MLNK 1.5B
- IPO Year
- NVAX 1995
- MLNK 2021
- Fundamental
- Price
- NVAX $8.64
- MLNK $19.94
- Analyst Decision
- NVAX Buy
- MLNK Hold
- Analyst Count
- NVAX 7
- MLNK 8
- Target Price
- NVAX $14.29
- MLNK $21.21
- AVG Volume (30 Days)
- NVAX 6.9M
- MLNK 412.1K
- Earning Date
- NVAX 11-11-2025
- MLNK 11-06-2025
- Dividend Yield
- NVAX N/A
- MLNK N/A
- EPS Growth
- NVAX N/A
- MLNK N/A
- EPS
- NVAX 2.54
- MLNK N/A
- Revenue
- NVAX $1,078,718,000.00
- MLNK $325,891,000.00
- Revenue This Year
- NVAX $61.69
- MLNK $6.47
- Revenue Next Year
- NVAX N/A
- MLNK $5.54
- P/E Ratio
- NVAX $3.18
- MLNK N/A
- Revenue Growth
- NVAX 9.22
- MLNK 5.96
- 52 Week Low
- NVAX $5.01
- MLNK $15.49
- 52 Week High
- NVAX $15.22
- MLNK $25.33
- Technical
- Relative Strength Index (RSI)
- NVAX 60.46
- MLNK 70.73
- Support Level
- NVAX $7.83
- MLNK $19.85
- Resistance Level
- NVAX $8.31
- MLNK $19.98
- Average True Range (ATR)
- NVAX 0.37
- MLNK 0.08
- MACD
- NVAX 0.05
- MLNK -0.12
- Stochastic Oscillator
- NVAX 99.49
- MLNK 56.52
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About MLNK MeridianLink Inc.
MeridianLink Inc is a cloud-based software solution for financial institutions, including banks, credit unions, mortgage lenders, specialty lending providers, and consumer reporting agencies. It generates maximum revenue from Lending Software Solutions.